- European Leukemia Net (ELN)
- European Research Initiative on CLL (ERIC)
- Universita Ulm, Prof. Stilgenbauer – úloha antionkogenu p53 u CLL
- Royal Bournemouth Hospital, Prof. Oscier - úloha antionkogenu p53 u CLL
- Universita Vita-Salute San Raffaele, Milano, Prof. Ghia – mutační status imunoglobulinů u CLL
- Papanicolaou Hospital, Greece, Dr. Stamatopoulos - mutační status imunoglobulinů u CLL
- University of Manchester, David Denning, Professor of Medicine and Medical Mycology – detekce mykotických patogenů v bronchoalveolární laváži
- Children's Cancer Research Institute, Vienna, Dr. Thomas Lion, – detekce mykotických patogenů v periferní krvi
- Projekt "EUTOS for CML-molecular monitoring" - Dr. Martin Muller, prof. Andreas Hochhaus, III. Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg
- Projekt "Armored RNA as reference materials for standardisation of BCR-ABL RQ-PCR methods: report of field trial evaluation" - Dr. Helen White, prof. Nick Cross, National Genetics Reference Laboratory (Wessex), Salisbury District Hospital
- Projekt "European Study Group on MRD detection in ALL (ESG-MRD-ALL + EWALL)" - Dr. Heike Pfeifer, Medizinische Klinik II, MRD-Labor, Universitätsklinik Frankfurt
- Dr. Olaf Merkel, Laboratory for Immunological and Molecular Cancer Research, IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology of the Paracelsus Medical University Salzburg, Austria -úloha microRNA u CLL
- Prof. Grzegorz S. Nowakowski, M.D., Dept. of Hematology, Mayo Clinic, Rochester, US - úloha mikroprostředí u lymfoproliferativních malignit
- CeMM Research Center for Molecular Medicine, Robert Kralovics, PhD.
Jihlavská 20, 625 00 Brno
Telefon: 532 23 1111
E-mail:
